What is Neogen's cash & equivalents?

Neogen (NEOG) reported cash & equivalents of $159.9M in Q4 2025.

How has Neogen's cash & equivalents changed year-over-year?

Neogen's cash & equivalents increased by 25.2% year-over-year, from $127.71M to $159.9M.

What is the long-term trend for Neogen's cash & equivalents?

Over 4 years (2021 to 2025), Neogen's cash & equivalents has grown at a 14.3% compound annual growth rate (CAGR), from $75.6M to $129M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Neogen NEOG Cash & Equivalents

Cash & Equivalents at other companies

Thermo Fisher ScientificTMO

$3.28B-21.4%

Idexx LaboratoriesIDXX

$200.53M+22.3%

ZoetisZTS

$1.94B+8.9%

RevvityRVTY

$861.47M-24.3%

TEC

Bio-TechneTECH

$209.82M+49.2%

Agilent TechnologiesA

$1.81B+21.5%

Other financials

Income statement

See full

Revenue$211.2M-4.4%

Gross profit$99.0M-10.2%

Operating income-$3.3M-161%

Net income-$17.0M-56.0%

EPS (diluted)-$0.08-60.0%

Balance sheet

See full

Total debt$793.3M-11.2%

Total equity$2.1B-21.0%

Total assets$3.4B-16.8%

Cash flow

See full

Operating cash flow$22.7M+16.7%

CapEx$11.6M-64.7%

Free cash flow$11.1M+182%

Valuation

See full

Market cap$1.92B+12.0%

Enterprise value$2.56B+4.4%

P/S2.2×+0.3×

Profitability

See full

Gross margin45.2%-3.6pp

Operating margin-73.1%+77.7pp

Net margin-69.9%+30.8pp

FCF margin-14%—

Returns & leverage

See full

Return on equity-25.6%+28.8pp

Debt / equity0.4×0.0×

Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neogen's cash & equivalents?: Neogen (NEOG) reported cash & equivalents of $159.9M in Q4 2025.
How has Neogen's cash & equivalents changed year-over-year?: Neogen's cash & equivalents increased by 25.2% year-over-year, from $127.71M to $159.9M.
What is the long-term trend for Neogen's cash & equivalents?: Over 4 years (2021 to 2025), Neogen's cash & equivalents has grown at a 14.3% compound annual growth rate (CAGR), from $75.6M to $129M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.